Safety and Efficacy Study of CBT-004 in Patients With Vascularized Pinguecula

Recruiting

Phase 2

CBT-004Safety and Efficacy Study of CBT-004 in Patients With Vascularized Pinguecula

Sponsor:

Cloudbreak Therapeutics, LLC

Code:

NCT04884256

Conditions

Pinguecula

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

CBT-004

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Cloudbreak Therapeutics, LLC on 2024-01-29.